SDC1 and infection: To ensure HSV1716 was not toxic to healthy cells, primary lymphocytes and BM samples (CD138− and CD138+ fractions) from healthy donors were infected with HSV1716 (MOI of 0.5 or 5) and the cell viability was assessed at 4, 5, and 6 days post-infection.